Reproducibility of meal-induced transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease

被引:7
作者
Boeckxstaens, GE
Hirsch, DP
Verkleij, CB
Lei, A
Holman, R
Lehmann, A
Rydholm, H
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands
[3] AstraZeneca R&D Molndal, Molndal, Sweden
关键词
gastro-oesophageal reflux; gastro-oesophageal reflux disease; transient lower oesophageal sphincter relaxations; variability;
D O I
10.1111/j.1365-2982.2004.00610.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: To calculate the number of subjects required in trials investigating drugs reducing the number of transient lower oesophageal sphincter relaxations (TLOSRs), the inter- and intra-individual variability of TLOSRs were determined, using meal ingestion as a trigger of TLOSRs and reflux. Methods: A total of 23 gastro-oesophageal reflux disease (GORD) patients with no to grade B oesophagitis and a hiatal hernia less than or equal to3 cm underwent oesophageal manometry and pHmetry 1 h before and 3 h after ingestion of a solid meal on two separate days approximately 4 weeks apart. Reflux episodes and the underlying mechanisms and the number of TLOSRs were evaluated. Results: The number of TLOSRs, reflux episodes and % time with pH < 4 after meal ingestion did not differ significantly between the two sessions. The intra-individual variation of TLOSRs in the 3 h postprandial period (24.4) was smaller compared with the inter-individual variation (47.5). Transient lower oesophageal sphincter relaxations were the predominant cause of reflux accounting for 61 +/- 7 and 70 +/- 5% of the reflux episodes in visits 1 and 2, respectively. Conclusions: These data for the first time provide information on the variability of TLOSRs and reflux evoked by meal ingestion, which is of crucial importance for the design and power calculations of future clinical studies evaluating the efficacy of new drugs targeting TLOSRs.
引用
收藏
页码:23 / 28
页数:6
相关论文
共 50 条
  • [31] Gastro-oesophageal reflux disease and bronchial asthma
    Patyk, Iwona
    Chcialowski, Andrzej
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2009, 5 (02): : 102 - 107
  • [32] Gastro-oesophageal reflux and interstitial lung disease
    Salvioli, B.
    Belmonte, G.
    Stanghellini, V.
    Baldi, E.
    Fasano, L.
    Pacilli, A. M. G.
    De Giorgio, R.
    Barbara, G.
    Bini, L.
    Cogliandro, R.
    Fabbri, M.
    Corinaldesi, R.
    DIGESTIVE AND LIVER DISEASE, 2006, 38 (12) : 879 - 884
  • [33] Gastro-oesophageal reflux disease: a brief review
    Selwood, Lisa
    SA PHARMACEUTICAL JOURNAL, 2015, 82 (01) : 12 - 16
  • [34] Infants and children with gastro-oesophageal reflux disease
    Schellack, Natalie
    SA PHARMACEUTICAL JOURNAL, 2012, 79 (01) : 14 - 19
  • [35] EndoCinch® treatment for gastro-oesophageal reflux disease
    Mahmood, Z.
    Ang, Y. S.
    DIGESTION, 2007, 76 (3-4) : 241 - 247
  • [36] Infant formula for gastro-oesophageal reflux disease
    Owens, C. J. W.
    Labuschagne, I. L.
    Lombard, M. J.
    SA PHARMACEUTICAL JOURNAL, 2013, 80 (03) : 28 - 30
  • [37] Lung diseases and gastro-oesophageal reflux disease
    Barroso Pereira, Joao Claudio
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2009, 15 (05) : 899 - 921
  • [38] Otolaryngologic manifestations of gastro-oesophageal reflux disease
    Klinkenberg-Knol, EC
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1998, 33 : 24 - 28
  • [39] Infant formula for gastro-oesophageal reflux disease
    Owens, C. J. W.
    Labuschagne, I. L.
    Lombard, M. J.
    SOUTH AFRICAN FAMILY PRACTICE, 2012, 54 (02) : 106 - 110
  • [40] Nonerosive reflux disease as a presentation of gastro-oesophageal reflux disease
    Simmonds, Wayne
    SA PHARMACEUTICAL JOURNAL, 2012, 79 (02) : 18 - 22